HCWB (HCW Biologics) 6-Month Price Index: 0.68 (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HCWB HCW Biologics Inc HCWB
37 GF Score
Price $2.41
GF Value $36.30
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is HCW Biologics 6-Month Price Index?

HCW Biologics HCWB +4.35% 37 6-Month Price Index is 0.68 as of Aug. 25, 2026. GuruFocus rates HCWB with a GF Score™ of 37/100 and a GF Value™ of $36.30 (Possible Value Trap). The stock has 7 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-08-25), HCW Biologics's 6-Month Price Index is 0.68.

HCW Biologics  (NAS:HCWB) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

HCW Biologics 6-Month Price Index Related Terms

HCWB vs GOVX, GLMD, SXTP: 6-Month Price Index Comparison

For the Biotechnology subindustry, HCW Biologics's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HCWB
37GF Score
HCW Biologics Inc HCWB
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HCW Biologics  (NAS:HCWB) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 0.68 mean?
HCW Biologics (HCWB) has a 6-Month Price Index of 0.68 as of Aug. 25, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on HCW Biologics and its competitors.
Is HCW Biologics' 6-Month Price Index too high?
HCW Biologics' current 6-Month Price Index is 0.68. Overall, HCW Biologics has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does HCW Biologics' 6-Month Price Index compare to GOVX and GLMD?
HCW Biologics' 6-Month Price Index of 0.68 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Biotechnology company?
A good 6-Month Price Index depends on the Biotechnology industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on HCW Biologics and its competitors. HCW Biologics's current 6-Month Price Index is 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCW Biologics stock overvalued right now?
Based on GuruFocus' analysis, HCW Biologics (HCWB) is currently considered Possible Value Trap. The stock's GF Value™ is $36.30, compared to a current price of $2.41 — trading 93.4% below its estimated fair value. The current 6-Month Price Index is 0.68. HCW Biologics' overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For HCW Biologics (HCWB), the current 6-Month Price Index is 0.68 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HCW Biologics (HCWB) Overvalued in 2026?

Based on GuruFocus' analysis, HCW Biologics stock appears to be undervalued. The current stock price of $2.41 is trading 93.4% below its estimated GF Value™ of $36.30. GuruFocus considers HCW Biologics to be Possible Value Trap.

Key valuation signals for HCWB:

  • 6-Month Price Index: 0.68
  • GF Value™: $36.30 vs. price of $2.41 (93.4% below fair value)
  • GF Score™: 37/100 with 7 warning signs

No single metric tells the full story. See the HCWB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HCW Biologics Business Description

Address 2929 N. Commerce Parkway, Miramar, FL, USA, 33025
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
37GF Score

Get the complete analysis for HCWB

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.41
Price
$36.30
GF Value